Patents by Inventor Kathleen M. Ward

Kathleen M. Ward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for enhancing contrast produced by MRI
    Publication number: 20080167549
    Abstract: A method for obtaining an image by MRI, comprising: administering at least one contrast agent to a subject in amounts effective to perform CEDST MRI analysis; and performing CEDST MRI analysis to produce an image of the subject. A number of different contrast agents can be used to practice the present method including, without limitation, sugars, amino acids, nitrogen-containing heterocycles, purines and pyrimidines, nucleosides; imidazole and derivatives thereof, imino acids, barbituric acid and analogs thereof, and miscellaneous materials, such as guanidine hydantoin, parabanic acid, and biologically active salts thereof.
    Type: Application
    Filed: December 17, 2007
    Publication date: July 10, 2008
    Inventors: Robert S. Balaban, Kathleen M. Ward, Anthony H. Aletras
  • Method for determining in vivo concentration of a metabolite
    Patent number: 7330748
    Abstract: Method for determining in vivo concentration of a metabolite that includes administering a contrast agent to a subject, allowing the contrast agent to disperse to tissue of interest, performing CEDST MRI analysis of the subject, and comparing the results to known in vitro results to determine metabolite concentration.
    Type: Grant
    Filed: September 24, 2004
    Date of Patent: February 12, 2008
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Robert S. Balaban, Kathleen M. Ward, Anthony H. Aletras
  • Method for enhancing contrast produced by MRI
    Patent number: 6963769
    Abstract: A method for obtaining an image by MRI, comprising: administering at least one contrast agent to a subject in amounts effective to perform CEDST MRI analysis; and performing CEDST MRI analysis to produce an image of the subject. A number of different contast agents can be used to practice the present method including, without limitation, sugars, animo acids, nitrogen-containing heterocycles, purines and pyrimidines, nucleosides; imidazole and derivatives thereof, imino acids, barbituric acid and analogs thereof, and miscellaneous materials, such as guanidine hydantoin, parabanic acid, and biologically active salts thereof.
    Type: Grant
    Filed: April 20, 2000
    Date of Patent: November 8, 2005
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Robert S. Balaban, Kathleen M. Ward, Anthony H. Aletras